# uptodate
- 南方医科大学珠江医院内分泌科两位医生翻译
- [跨性别女性的评估和管理](https://www.uptodate.com/contents/zh-Hans/transgender-women-evaluation-and-management)
- [跨性别男性的评估与管理](https://www.uptodate.com/contents/zh-Hans/transgender-men-evaluation-and-management)
# MtF性功能
- 睾酮含量与夜间勃起有关，与刺激后勃起没有显著关联  
[雄激素耗竭对人类勃起功能的影响：一项针对男性到女性变性者的前瞻性研究 Bettocchi, C., Palumbo, F., Cormio, L., Ditonno, P., Battaglia, M., & Selvaggi, F. P. (2004). The effects of androgen depletion on human erectile function: a prospective study in male-to-female transsexuals. International journal of impotence research, 16(6), 544-546.](https://doi.org/10.1038/sj.ijir.3901216)
- 阴茎组织萎缩与缺乏勃起有强相关  
勃起障碍可使用PED-5抑制剂和真空辅助勃起  
(参考前列腺切除后的勃起障碍)
- 重点HRT或SRS后性生活质量和治疗手段  
[支持跨性别者的性行为和改善性功能 Holmberg, M., Arver, S., & Dhejne, C. (2019). Supporting sexuality and improving sexual function in transgender persons. Nature Reviews Urology, 16(2), 121-139.](https://doi.org/10.1038/s41585-018-0108-8)
- HRT开始后性欲下降,两年后性欲上升至高于HRT开始前的水平.MtF性腺切除导致两年后更高的性欲水平.  
[开始激素治疗后跨性别个体的性欲变化：欧洲性别不一致调查纵向网络的结果 Defreyne, J., Elaut, E., Kreukels, B., Fisher, A. D., Castellini, G., Staphorsius, A., ... & T'Sjoen, G. (2020). Sexual desire changes in transgender individuals upon initiation of hormone treatment: results from the longitudinal European Network for the Investigation of Gender Incongruence. The journal of sexual medicine, 17(4), 812-825.](https://doi.org/10.1016/j.jsxm.2019.12.020)
- [Positive and Negative Affect Changes during Gender-Affirming Hormonal Treatment: Results from the European Network for the Investigation of Gender Incongruence (ENIGI) ](https://doi.org/10.3390/jcm10020296)
- 对比无治疗,HRT,HRT+SRS性功能障碍患病率  
[跨性别者性功能障碍的患病率：ENIGI 后续研究的结果 Kerckhof, M. E., Kreukels, B. P., Nieder, T. O., Becker-Hébly, I., van de Grift, T. C., Staphorsius, A. S., ... & Elaut, E. (2019). Prevalence of sexual dysfunctions in transgender persons: results from the ENIGI follow-up study. The journal of sexual medicine, 16(12), 2018-2029.](https://doi.org/10.1016/j.jsxm.2019.09.003)
# 乳房发育
- 螺内酯和自行用药与隆胸率相关,醋酸环丙孕酮与抑郁相关  
[乳房成形术的预测标志物和服用各种激素方案的变性女性的副作用比较 Seal, L. J., Franklin, S., Richards, C., Shishkareva, A., Sinclaire, C., & Barrett, J. (2012). Predictive markers for mammoplasty and a comparison of side effect profiles in transwomen taking various hormonal regimens. The Journal of Clinical Endocrinology & Metabolism, 97(12), 4422-4428.](https://doi.org/10.1210/jc.2012-2030)
- 孕激素没有明确证据增加乳房发育  
[临床评论：接受异性激素的跨性别女性的乳房发育 Wierckx, K., Gooren, L., & T'Sjoen, G. (2014). Clinical review: breast development in trans women receiving cross-sex hormones. The journal of sexual medicine, 11(5), 1240-1247.](https://doi.org/10.1111/jsm.12487)
- 睾酮水平与起始醋酸环丙孕酮剂量无关，乳房发育阶段与睾酮负相关  
[基于指南的性别肯定激素疗法的安全性和快速疗效：对 388 名诊断为性别不安的个体的分析 Meyer, G., Mayer, M., Mondorf, A., Fluegel, A. K., Herrmann, E., & Bojunga, J. (2020). Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria. European Journal of Endocrinology, 182(2), 149-156.](https://doi.org/10.1530/EJE-19-0463)
- 黄体酮可能有效的临床经验(口服微粉化黄体酮(Oral micronized progesterone))  
[黄体酮对跨性别女性的治疗很重要——应用证据证明黄体酮对女性的益处 Prior, J. C. (2019). Progesterone is important for transgender women’s therapy—applying evidence for the benefits of progesterone in ciswomen. The Journal of Clinical Endocrinology & Metabolism, 104(4), 1181-1186.](https://doi.org/10.1210/jc.2018-01777)  
反对意见:过早且有潜在危险  
[给编辑的信：“黄体酮对跨性别女性的治疗很重要——应用证据证明黄体酮对女性的益处” Iwamoto, S. J., T’Sjoen, G., Safer, J. D., Davidge-Pitts, C. J., Wierman, M. E., Glodowski, M. B., & Rothman, M. S. (2019). Letter to the Editor:“Progesterone is important for transgender women’s therapy—Applying evidence for the benefits of progesterone in ciswomen”. The Journal of Clinical Endocrinology & Metabolism, 104(8), 3127-3128.](https://doi.org/10.1210/jc.2019-00249)
回复:然而，我向作者提出挑战，以证明在跨性别女性的 GAHT 中添加黄体酮是有害的。  
[回复给给编辑的信：“黄体酮对跨性别女性的治疗很重要——应用证据证明黄体酮对女性的益处” Prior, J. C. (2019). Response to Letter to the Editor:“Progesterone is important for transgender women’s therapy—Applying evidence for the benefits of progesterone in ciswomen”. The Journal of Clinical Endocrinology & Metabolism, 104(8), 3129-3130.](https://doi.org/10.1210/jc.2019-00524)
- 理论综述  
[顺性别女性乳房发育回顾及对跨性别女性的影响 Reisman, T., Goldstein, Z., & Safer, J. D. (2019). A review of breast development in cisgender women and implications for transgender women. Endocrine Practice, 25(12), 1338-1345.](https://doi.org/10.4158/EP-2019-0183)
- 同样醋酸环丙孕酮治疗下无明显差别，2年-3年间乳房容积下降(无法解释,与2年HRT后SRS显著有关，调整数据考虑年龄和血清激素水平后不显著相关)  
[跨性激素治疗 1 年后，跨性别女性的乳房发育：一项前瞻性多中心研究的结果 de Blok, C. J. M., Klaver, M., Wiepjes, C. M., Nota, N. M., Heijboer, A. C., Fisher, A. D., ... & den Heijer, M. (2018). Breast development in transwomen after 1 year of cross-sex hormone therapy: results of a prospective multicenter study. The Journal of Clinical Endocrinology & Metabolism, 103(2), 532-538.](https://doi.org/10.1210/jc.2017-01927)  
[性别肯定激素治疗 3 年的持续乳房发育和乳房人体测量学变化 de Blok, C. J., Dijkman, B. A., Wiepjes, C. M., Staphorsius, A. S., Timmermans, F. W., Smit, J. M., ... & den Heijer, M. (2021). Sustained Breast Development and Breast Anthropometric Changes in 3 Years of Gender-Affirming Hormone Treatment. The Journal of Clinical Endocrinology & Metabolism, 106(2), e782-e790.](https://doi.org/10.1210/clinem/dgaa841)
- sci-hub暂时无法获取  
[男性到女性跨性别患者的胸部女性化：选项回顾 Patel, H., Samaha, Y., Ives, G., Lee, T. Y., Cui, X., & Ray, E. (2021). Chest Feminization in Male-to-Female Transgender Patients: A Review of Options. Transgender Health.](https://doi.org/10.1089/trgh.2020.0057)
# 睾酮水平
- 醋酸环丙孕酮抗雄效果好于螺内酯  
[醋酸环丙孕酮或螺内酯降低接受雌二醇治疗的跨性别者的睾酮浓度Angus, L., Leemaqz, S., Ooi, O., Cundill, P., Silberstein, N., Locke, P., ... & Cheung, A. S. (2019). Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy. Endocrine connections, 8(7), 935-940.](https://doi.org/10.1530/EC-19-0272)
# 综述
- 英国免费提供GnRH
- 等待WPATH护理标准v8(目前v7)  
预计2021年出版  
[WPATH护理标准](https://www.wpath.org/publications/soc)
- sci-hub暂时无法获取  
[内分泌疾病的管理：变性人的最佳女性化激素治疗 Glintborg, D., T'Sjoen, G., Ravn, P., & Andersen, M. S. (2021). Management of endocrine disease: Optimal feminizing hormone treatment in transgender people. European Journal of Endocrinology, 1(aop).](https://doi.org/10.1530/EJE-21-0059)
# 工具
- [TransBox - HRT相关的小工具们](https://github.com/Pix-00/TransBox)
- [transHelper跨儿助手](https://github.com/MsZhu-trans/transHelper-release)
# 文档库
- [Transgender-lost-years](https://github.com/KristallWang/Transgender-lost-years)
- [MtF Wiki](https://mtf.wiki/)
- [跨性别在线·文档库](https://docs.transonline.org.cn/)
# 链接待查
- [JANUARY 4, 2021 BY 神楽坂梓月(twitter @ziyue_shizuki)  
跨性别激素治疗（THT）指南 – 女性型](http://opengl106.oikawa.moe/2021/01/04/transgender-hormone-therapy-mtf-instructions/)
-[wiki Portal:Transgender](https://en.wikipedia.org/wiki/Portal:Transgender)
- [比卡鲁胺wiki](https://en.wikipedia.org/wiki/Medical_uses_of_bicalutamide#Transgender_hormone_therapy)
- [MtF HRT](https://en.wikipedia.org/wiki/Feminizing_hormone_therapy)
- [MtF HRT 资料 (v1.05) by shizu twitter @shizunyan_](https://docs.google.com/presentation/d/1PzE-rmtwBMOrgXcsI_RIDAKTUIe3fx5h-PmEbzRgBBA/edit#slide=id.gd20f122bcb_13_0)  
注意文末参考资料
- GnRH效果价格待查
- 研究事实汇总[transfem science](https://transfemscience.org/articles/)
- MtF指南汇总[Clinical Guidelines with Information on Transfeminine Hormone Therapy](https://transfemscience.org/articles/transfem-hormone-guidelines/)
# 精神科诊疗
## 疾病
- 精神障碍诊疗规范（2020年版）  
第十三章第九节：性身份障碍
- DSM-5  
性别烦躁(gender dysphoria)
- ICD1-11  
性别不一致 (HA60-HA6Z)
青春期或成年期性别不符
## 指南
### 中文
- UpToDate  
[跨性别女性的评估和管理](https://www.uptodate.com/contents/zh-Hans/transgender-women-evaluation-and-management)  
[跨性别男性的评估与管理](https://www.uptodate.com/contents/zh-Hans/transgender-men-evaluation-and-management)
- [跨性别在线·文档库](https://docs.transonline.org.cn/)  
WPATH SOC V7，UCSF指南，内分泌协会指南(2017)，
- [UNDP]亚太跨性别健康蓝图
- [临床综述 l EndoRev2018-跨性别医学的内分泌学（全文）** ](https://mp.weixin.qq.com/s?__biz=MzIwMTk4MzY2OQ==&mid=2247494445&idx=1&sn=7493ba14eb2ad803343ce2dc5bea9e44&chksm=96e738f7a190b1e189dd3e1bead008dbbe34ed4712f0f9d4c0b341905fec14cd34908c48298e&mpshare=1&scene=22&srcid=1207unB0Q2ATbJoT4m3hjku3&sharer_sharetime=1638874230059&sharer_shareid=a9f3bd4ed6184c7d70934f10bb760b11#rd)
- [指南共识 l 2017美国ES指南-性别焦虑/性别不一致人群的内分泌治疗（中文全文+链接）** ](https://mp.weixin.qq.com/s?__biz=MzIwMTk4MzY2OQ==&mid=2247490794&idx=1&sn=7541901b0836ce40a0ef2ed683744c60&chksm=96e4cf30a193462617f755fead75cd1606d94db9e0e36367c8c99ea06367d5ca704804fe87e0&scene=21#wechat_redirect)
### 英文
- [Clinical Guidelines with Information on Transfeminine Hormone Therapy](https://transfemscience.org/articles/transfem-hormone-guidelines/)

[泰国人妖的问题，你听过的答案基本都是错的](https://zhuanlan.zhihu.com/p/53722139)